Of 6263 patients, 3131 were randomized to dapagliflozin 10 mg and 3132 to placebo and were followed for a median of 28 months
The Phase 2 trial showed 22.8% average body weight reduction at 48 weeks in the 8mg group
TRIUMPH-4 was shorter than SURMOUNT-1, smaller, and the population had knee osteoarthritis, which can affect how easily people stay active
"Shifts in taste may affect how satisfying or appealing food feels in the moment, which influences appetite control, " said Othmar Moser, a professor at the University of Bayreuth in Germany who led the study
Semaglutide is an FDA-approved medication designed to support weight loss by reducing appetite and enhancing feelings of fullness
How tirzepatide and retatrutide actually work Understanding the difference between these two peptides starts at the receptor level